N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction

Respirology

Volumn 17, Issue 4, 2012, Pages 660-666

  Ouanes, Islem ^a   Jalloul, Faten ^a   Ayed, Samia ^b   Dachraoui, Fahmi ^a   Ouanes Besbes, Lamia ^a   Fekih Hassen, Mohamed ^b   Elatrous, Souheil ^b   Abroug, Fekri ^a  

^a FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^b UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

B type natriuretic peptide; chronic obstructive pulmonary disease; exacerbation; left ventricular dysfunction; renal dysfunction

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE EXACERBATION; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE FAILURE; HUMAN; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AGED; COMORBIDITY; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; KIDNEY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; ROC CURVE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84859900744     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2012.02153.x     Document Type: Article

References (34)

1. Masa JF, Jimenez A, Duran J, et al,. Alternative methods of titrating continuous positive airway pressure: a large multicenter study. Am. J. Respir. Crit. Care Med. 2004; 170: 1218-24. (Pubitemid 39577381)
2. Anto JM, Vermeire P, Vestbo J, et al,. Epidemiology of chronic obstructive pulmonary disease. Eur. Respir. J. 2001; 17: 982-94. (Pubitemid 32600349)
3. Masa JF,. [Continuous positive airway pressure titration: manual, automatic, or empirical?]. Arch. Bronconeumol. 2004; 40: 147-8. (Pubitemid 38661188)
4. Le Jemtel TH, Padeletti M, Jelic S,. Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J. Am. Coll. Cardiol. 2007; 49: 171-80. (Pubitemid 46054390)
5. Rutten FH, Cramer MJ, Grobbee DE, et al,. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur. Heart J. 2005; 26: 1887-94. (Pubitemid 41253302)
6. Rutten FH, Moons KG, Cramer MJ, et al,. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 2005; 331: 1379-86.
7. Groenning BA, Raymond I, Hildebrandt PR, et al,. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. Heart 2004; 90: 297-303. (Pubitemid 38250725)
8. Maisel AS, Krishnaswamy P, Nowak RM, et al,. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N. Engl. J. Med. 2002; 347: 161-7. (Pubitemid 34764819)
9. Hobbs FD, Davis RC, Roalfe AK, et al,. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ 2002; 324: 1498-1502.
10. Abroug F, Ouanes-Besbes L, Nciri N, et al,. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers. Am. J. Respir. Crit. Care Med. 2006; 174: 990-6. (Pubitemid 44684447)
11. Bando M, Ishii Y, Sugiyama Y, et al,. Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale. Respir. Med. 1999; 93: 507-14. (Pubitemid 29364066)
12. Abroug F, Ouanes-Besbes L,. Detection of acute heart failure in chronic obstructive pulmonary disease patients: role of B-type natriuretic peptide. Curr. Opin. Crit. Care 2008; 14: 340-7. (Pubitemid 351667921)
13. Cataliotti A, Malatino LS, Jougasaki M, et al,. Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin. Proc. 2001; 76: 1111-19. (Pubitemid 33032388)
14. Clerico A, Caprioli R, Del Ry S, et al,. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis. J. Endocrinol. Invest. 2001; 24: 24-30. (Pubitemid 32166325)
15. Srisawasdi P, Vanavanan S, Charoenpanichkit C, et al,. The effect of renal dysfunction on BNP, NT-proBNP, and their ratio. Am. J. Clin. Pathol. 2009; 133: 14-23.
16. Luchner A, Weidemann A, Willenbrock R, et al,. Improvement of the cardiac marker N-terminal-pro brain natriuretic peptide through adjustment for renal function: a stratified multicenter trial. Clin. Chem. Lab. Med. 2010; 48: 121-8.
17. Luchner A, Hengstenberg C, Lowel H, et al,. N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function. Hypertension 2002; 39: 99-104. (Pubitemid 34098096)
18. Coquet I, Darmon M, Doise JM, et al,. Performance of N-terminal-pro-B- type natriuretic peptide in critically ill patients: a prospective observational cohort study. Crit. Care 2008; 12: R137.
19. Luchner A, Hengstenberg C, Lowel H, et al,. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP. Hypertension 2005; 46: 118-23. (Pubitemid 40946501)
20. Escande M, Mordarska M, Marsoubian L,. [B-type natriuretic peptide levels and renal function in the diagnosis of heart failure in the elderly]. Ann. Cardiol. Angeiol. (Paris) 2010; 59: 260-2.
21. deFilippi CR, Seliger SL, Maynard S, et al,. Impact of renal disease on natriuretic peptide testing for diagnosing decompensated heart failure and predicting mortality. Clin. Chem. 2007; 53: 1511-19. (Pubitemid 47206349)
22. Anwaruddin S, Lloyd-Jones DM, Baggish A, et al,. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J. Am. Coll. Cardiol. 2006; 47: 91-7. (Pubitemid 43005170)
23. Global Strategy for Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Updated 2010. [Accessed October 2011.] Available from URL:.
24. Brochard L, Mancebo J, Wysocki M, et al,. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N. Engl. J. Med. 1995; 333: 817-22.
25. Levey AS, Coresh J, Greene T, et al,. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann. Intern. Med. 2006; 145: 247-54. (Pubitemid 46768608)
26. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2002; 39 (2 Suppl. 1): S1-266.
27. Cockroft DW, Gault MH,. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
28. Januzzi JL Jr, Camargo CA, Anwaruddin S, et al,. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am. J. Cardiol. 2005; 95: 948-54. (Pubitemid 40487743)
29. Yap LB, Mukerjee D, Timms PM, et al,. Natriuretic peptides, respiratory disease, and the right heart. Chest 2004; 126: 1330-6. (Pubitemid 39391268)
30. Yap L, Ashrafian H, Mukerjee D, et al,. The natriuretic peptides and their role in disorders of right heart dysfunction and pulmonary hypertension. Clin. Biochem. 2004; 37: 847-56. (Pubitemid 39209023)
31. Ray P, Arthaud M, Birolleau S, et al,. Comparison of brain natriuretic peptide and probrain natriuretic peptide in the diagnosis of cardiogenic pulmonary edema in patients aged 65 and older. J. Am. Geriatr. Soc. 2005; 53: 643-8. (Pubitemid 41623487)
32. McCullough PA, Duc P, Omland T, et al,. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am. J. Kidney Dis. 2003; 41: 571-9. (Pubitemid 36278374)
33. Inoue Y, Kawayama T, Iwanaga T, et al,. High plasma brain natriuretic peptide levels in stable COPD without pulmonary hypertension or cor pulmonale. Intern. Med. 2009; 48: 503-12.
34. Gale CP, White JE, Hunter A, et al,. Predicting mortality and hospital admission in patients with COPD: significance of NT pro-BNP, clinical and echocardiographic assessment. J. Cardiovasc. Med. (Hagerstown) 2011; 12: 613-18.